1. Synergistic Effect of TPD7 and Berberine against Leukemia Jurkat Cell Growth through Regulating Ephrin‐B2 Signaling
   Weina Ma et al, 2017, Phytotherapy Research CrossRef
2. High serum Ephrin‑B2 levels predict poor prognosis for patients with gastric cancer
   Wen‑Jing Yue et al, 2018, Oncology Letters CrossRef
3. Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma
   Mohd. Altaf Najar et al, 2022, Frontiers in Genetics CrossRef
4. Purification of Gekko Small Peptide Fraction and Its Effect of Inducing Apoptosis of EC 9706 Esophageal Cancer Cells by Inhibiting PI3K/Akt/GLUT1 Signaling Pathway
   Xingzhi Lv et al, 2021, Chemistry & Biodiversity CrossRef
5. Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination
   Shelby Lennon et al, 2019, Clinical Cancer Research CrossRef
6. The potential roles of p53 signaling reactivation in pancreatic cancer therapy
   Aixin Ou et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. Short interfering RNA in colorectal cancer: is it wise to shoot the messenger?
   Kiruthiga Chandramohan et al, 2023, European Journal of Pharmacology CrossRef
8. Targeting siRNA in colorectal cancer therapy: Nanotechnology comes into view
   Shahin Aghamiri et al, 2019, Journal of Cellular Physiology CrossRef
9. Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer
   L. Yang et al, 2021, Clinical and Translational Oncology CrossRef
10. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT
    Feng Zhu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
11. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets
    João Figueira Scarini et al, 2024, Frontiers in Oncology CrossRef